BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25350728)

  • 1. Blockade and reversal of spinal morphine tolerance by P2X3 receptor antagonist.
    Ma X; Xu T; Xu H; Jiang W
    Behav Pharmacol; 2015 Apr; 26(3):260-7. PubMed ID: 25350728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
    McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice.
    Hansen RR; Nasser A; Falk S; Baldvinsson SB; Ohlsson PH; Bahl JM; Jarvis MF; Ding M; Heegaard AM
    Eur J Pharmacol; 2012 Aug; 688(1-3):27-34. PubMed ID: 22634164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration.
    McGaraughty S; Wismer CT; Zhu CZ; Mikusa J; Honore P; Chu KL; Lee CH; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2003 Dec; 140(8):1381-8. PubMed ID: 14623769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tianeptine reduces morphine antinociceptive tolerance and physical dependence.
    Chu CC; Shieh JP; Shui HA; Chen JY; Hsing CH; Tzeng JI; Wang JJ; Ho ST
    Behav Pharmacol; 2010 Sep; 21(5-6):523-9. PubMed ID: 20679893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords.
    Lin SL; Tsai RY; Tai YH; Cherng CH; Wu CT; Yeh CC; Wong CS
    Behav Brain Res; 2010 Feb; 207(1):30-6. PubMed ID: 19799935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-low dose naloxone restores the antinocicepitve effect of morphine in PTX-treated rats: association of IL-10 upregulation in the spinal cord.
    Lin YS; Tsai RY; Shen CH; Chien CC; Tsai WY; Guo SL; Wong CS
    Life Sci; 2012 Sep; 91(5-6):213-20. PubMed ID: 22820166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
    Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
    Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord.
    Dogrul A; Seyrek M
    Br J Pharmacol; 2006 Nov; 149(5):498-505. PubMed ID: 16921395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxin A4 analog attenuates morphine antinociceptive tolerance, withdrawal-induced hyperalgesia, and glial reaction and cytokine expression in the spinal cord of rat.
    Jin H; Li YH; Xu JS; Guo GQ; Chen DL; Bo Y
    Neuroscience; 2012 Apr; 208():1-10. PubMed ID: 22366510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
    Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous firing and evoked responses of spinal nociceptive neurons are attenuated by blockade of P2X3 and P2X2/3 receptors in inflamed rats.
    Xu J; Chu KL; Brederson JD; Jarvis MF; McGaraughty S
    J Neurosci Res; 2012 Aug; 90(8):1597-606. PubMed ID: 22422599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroacupuncture and A-317491 depress the transmission of pain on primary afferent mediated by the P2X3 receptor in rats with chronic neuropathic pain states.
    Wang WS; Tu WZ; Cheng RD; He R; Ruan LH; Zhang L; Gong YS; Fan XF; Hu J; Cheng B; Lai YP; Zou EM; Jiang SH
    J Neurosci Res; 2014 Dec; 92(12):1703-13. PubMed ID: 25041872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion.
    Ibuki T; Dunbar SA; Yaksh TL
    Pain; 1997 Apr; 70(2-3):125-32. PubMed ID: 9150285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
    Dunbar SA; Karamian I; Zhang J
    Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.